Prevalence and growth characteristics of malignant stem cells in B-lineage acute lymphoblastic leukemia
- PMID: 9160679
Prevalence and growth characteristics of malignant stem cells in B-lineage acute lymphoblastic leukemia
Abstract
We used a stroma-supported culture method to study the prevalence and growth characteristics of malignant stem cells in acute lymphoblastic leukemia (ALL). In 51 of 108 B-lineage ALL samples, bone marrow-derived stroma not only inhibited apoptosis of ALL cells but also supported their proliferation in serum-free medium. When single leukemic cells were placed in the stroma-coated wells of microtiter plates, the percentage of wells with leukemic cell growth after 2 to 5 months of culture ranged from 6% to 20% (median, 15%; 5 experiments). The immunophenotypes and genetic features of cells recovered from these cultures were identical to those noted before culture. All cells maintained their stroma dependency and self-renewal capacity. Leukemic clones derived from single cells contained approximately 10(3) to 10(6) cells after 1 month of culture; other clones became detectable only after prolonged culture. Cell growth in stroma-coated wells correlated with the number of initially seeded cells (1 or 10; r = .87). However, the observed percentages of positive wells seeded with 10 cells always exceeded values predicted from results with single-cell-initiated cultures (P < .003 by paired t-test), suggesting stimulation of leukemic cell growth by paracrine factors. In conclusion, the proportion of ALL cells with clonogenic potential may be considerably higher than previously thought.
Similar articles
-
Bone marrow-derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblastic leukemia.Blood. 1992 May 1;79(9):2370-7. Blood. 1992. PMID: 1373973
-
Long-term survival and proliferation of precursor-B acute lymphoblastic leukemia cells on human bone marrow stroma.Leukemia. 1996 May;10(5):813-20. Leukemia. 1996. PMID: 8656676
-
Clinical relevance of BCL-2 overexpression in childhood acute lymphoblastic leukemia.Blood. 1996 Feb 1;87(3):1140-6. Blood. 1996. PMID: 8562940
-
Immunophenotypes in adult acute lymphocytic leukemia. Role of flow cytometry in diagnosis and monitoring of disease.Hematol Oncol Clin North Am. 2000 Dec;14(6):1251-65. doi: 10.1016/s0889-8588(05)70185-4. Hematol Oncol Clin North Am. 2000. PMID: 11147222 Review.
-
[Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].Folia Med Cracov. 2001;42(3):5-80. Folia Med Cracov. 2001. PMID: 12353422 Review. Polish.
Cited by
-
VE-cadherin Regulates Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Sensitivity to Apoptosis.Cancer Microenviron. 2010 Mar 2;3(1):67-81. doi: 10.1007/s12307-010-0035-6. Cancer Microenviron. 2010. PMID: 21209775 Free PMC article.
-
CD10 is a marker for cycling cells with propensity to apoptosis in childhood ALL.Br J Cancer. 2002 Jun 5;86(11):1776-85. doi: 10.1038/sj.bjc.6600329. Br J Cancer. 2002. PMID: 12087466 Free PMC article.
-
Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase.J Clin Invest. 2007 Apr;117(4):1049-57. doi: 10.1172/JCI30235. Epub 2007 Mar 22. J Clin Invest. 2007. PMID: 17380207 Free PMC article.
-
Cancer associated fibroblasts in hematological malignancies.Oncotarget. 2015 Feb 20;6(5):2589-603. doi: 10.18632/oncotarget.2661. Oncotarget. 2015. PMID: 25474039 Free PMC article. Review.
-
Stromal cell-mediated mitochondrial redox adaptation regulates drug resistance in childhood acute lymphoblastic leukemia.Oncotarget. 2015 Dec 15;6(40):43048-64. doi: 10.18632/oncotarget.5528. Oncotarget. 2015. PMID: 26474278 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources